Hereditary leiomyomatosis and acute lymphoblastic leukemia: A link through fumarate dyshydratase mutation?

References

• Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A. 2001;98(6):3387–3392.
   Google Scholar
• Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014;13(4):637–644.
   Google Scholar
• Gardie B, Remenieras A, Kattygnarath D, et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet. 2011;48(4):74–80.
   Google Scholar
• Arenas VC, Rodríguez LML, Cardona BAY, et al. Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family. Fam Cancer. 2017;16(1):117–122.
   Google Scholar
• Alam NA, Bevan S, Churchman M, et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet. 2001;68(5):1264–1269.
   Google Scholar
• Alam N, Barclay E, Rowan AJ, et al. Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. Arch Dermatol. 2005;141(2):199–206.
   Google Scholar
• Smit DL, Mensenkamp AR, Badeloe S, et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011;79(1):49–59.
   Google Scholar
• Jabbour E, O’Brien S, Konopleva M, et al. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015;121:2517–2528.
   Google Scholar
• Liu Y, Easton J, Shao Y, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49(8):1211–1218.
   Google Scholar
• Medinger M, Heim D, Lengerke C, et al. Akute Lymphoblastische Leukämie – diagnostik und Therapie. Ther Umsch. 2019;76(9):510–515.
   Google Scholar
• Beldjord K, Chevret S, Asnafi V, et al. Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL). Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014;123(24):3739–3749.
   Google Scholar
• MH W, Toure O, Gm G, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2005;43(1):18–27.
   Google Scholar
• Gironi L, Pasini B, Farinelli P, et al. Hereditary leiomyomatosis and renal cell cancer: do you know this syndrome? J Pathol Micro. 2016;1. 1–3.
   Google Scholar
• Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73(1):95–106.
   Google Scholar
• Pithukpakorn M, et al. Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006;43(9):755–762.
   Google Scholar
• Sanz-Ortega J, Vocke C, Stratton P, et al. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol. 2013;37(1):74–80.
   Google Scholar
• Patel VM, Handler MZ, Schwartz RA, et al. Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review. J Am Acad Dermatol. 2017;77(1):149–158.
   Google Scholar
• Muller M, Ferlicot S, Guillaud-Bataille M, et al. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet. 2017;92(6):606–615.
   Google Scholar
• Weiler L, Poulalhon N, Slama A, et al. Isolated cutaneous leiomyosarcoma revealing a novel germline mutation of fumarate hydratase gene. Br J Dermatol. 2016;175(5):1104–1106.
   Google Scholar
• Apatenko AK, Turusov VS. The painful tumours of the skin. Neoplasma. 1968;15:187–202.
   Google Scholar
• Garman ME, Blumberg MA, Ernst R, et al. Familial leiomyomatosis: a review and discussion of pathogenesis. Dermatology. 2003;207(2):210–213.
   Google Scholar
• Emer JJ, Solomon S, Mercer SE. Reed’s syndrome: a case of multiple cutaneous and uterine leiomyomas. J Clin Aesthet Dermatol. 2011;4:37–42.
   Google Scholar
• Wang C, Tetzlaff M, Hick R, et al. Reed syndrome presenting with leiomyosarcoma. JAAD Case Rep. 2015;1(3):150–152.
   Google Scholar
• Schmidt LS, Linehan WM. Hereditary leiomyomatosis and renal cell carcinoma. International Journal of Nephrology and Renovascular Disease. 2014;7:253–260.
   Google Scholar
• Ekanem E, Talaulikar V. Medical therapy for fibroids: what next for ulipristal acetate? Adv Ther. 2021;202(38):137–148
   Google Scholar
• Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005;153(1):11–17.
   Google Scholar
• Basendwh MA, Fatani M, Baltow B. Reed’s Syndrome: a Case of Multiple Cutaneous Leiomyomas Treated with Liquid Nitrogen Cryotherapy. Case Rep Dermatol. 2016;8(1):65–70.
   Google Scholar
• Hansen AW, Chayed Z, Pallesen K, et al. Hereditary Leiomyomatosis and Renal Cell Cancer. Acta Derm Venereol. 2020;100. DOI:https://doi.org/10.2340/00015555-3366.
   Google Scholar
• Malik K, Patel P, Chen J, et al. Leiomyoma cutis: a focused review on presentation, management, and association with malignancy. Am J Clin Dermatol. 2015;16(1):35–46.
   Google Scholar
• Tomlinson IP, Alam NA, Rowan AJ, et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30:406–410.
   Google Scholar
• Bayley JP, Launonen V, Tomlinson IP. The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet. 2008;25(1):20.
   Google Scholar
• Linehan WM, Rouault TA. Molecular Pathways: fumarate Hydratase -Deficient Kidney Cancer—Targeting the Warburg Effect in Cancer. Clin Cancer Res. 2013;19(13):150–152.
   Google Scholar
• Schmidt C, Sciacovelli M, Frezza C. Fumarate hydratase in cancer: a multifaceted tumour suppressor. Semin Cell Dev Biol. 2020;98:15–25.
   Google Scholar
• Ha Y-S, Chihara Y, Yoon H-Y, et al. Downregulation of fumarate hydratase Is related to tumorigenesis in sporadic renal cell cancer. Urol Int. 2013;90(2):233–239.
   Google Scholar
• Zhang J, Walsh MF, Wu G, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373(24):2336–2346.
   Google Scholar
• Fieuw A, Kumps C, Schramm A, et al. Identification of a novel recurrent 1q42.2-1qter deletion. in Schmidt et al. Page 14 Semin Cell Dev Biol. Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts high risk MYCN single copy 11q deleted neuroblastomas. Int J Cancer. 2011;130(11):2599–2606.
   Google Scholar
• Castro-Vega LJ, Buffet A, De Cubas AA, et al. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet. 2014;23:2440–2446.
   Google Scholar
• Hu J, Locasale JW, Bielas JH, et al. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol. 2013;31(6):522.
   Google Scholar
• Frezza C, Pollard PJ, Gottlieb E. Inborn and acquired metabolic defects in cancer. J Mol Med. 2011;89(3):213–220.
   Google Scholar
• Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, et al. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet. 2006;43(6):523–526.
   Google Scholar
• Guitart AV, Panagopoulou TI, Villacreces A, et al. Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions. J Exp Med. 2017;214(3):719–735.
   Google Scholar